Article Text

Download PDFPDF
Remission and relapse of Crohn’s disease following autologous haematopoietic stem cell transplantation for non-Hodgkin’s lymphoma
  1. V Anumakonda,
  2. B Hayee,
  3. G Chung-Faye
  1. Department of Gastroenterology, King’s College Hospital, London SE5 9RS, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Autologous haematopoietic stem cell transplantation (HSCT) for Crohn’s disease has been described by Oyama and co-workers as producing remission in 11 of 12 patients with refractory Crohn’s disease after a median follow up of 18.5 months.1 They postulated that autologous HSCT was useful for refractory Crohn’s disease. We report the case of a 32 year old woman with biopsy proven Crohn’s disease diagnosed when she was 16 years old. Her mother also suffered from Crohn’s disease. She developed a KI1 positive anaplastic non-Hodgkin’s lymphoma (NHL) three years later, treated successfully with ablative CHOP chemotherapy and autologous HSCT, inducing remission for …

View Full Text


  • Conflict of interest: None declared.